HEALTH
Medicare to Cover Weight Loss Drugs: A $35 Billion Deal
USAFri Nov 07 2025
Key Details
- Effective Date: January 2026
- Drugs Covered: Ozempic, Wegovy, and other weight loss medications
- Price Reductions:
- Ozempic: $350/month (down from $1,000)
- Wegovy: $350/month (down from $1,350)
- Other Drugs: Around $145/month
Background
Until recently, Medicare could not cover drugs solely for weight loss. The rules have been evolving as these drugs also show benefits for heart disease. However, covering weight loss alone has been slow due to outdated regulations and cost concerns.
Financial Impact
- Government Cost: The deal is expected to add $35 billion to federal spending from 2026 to 2034.
- Cost per Person: Around $5,600 in 2026.
- National Debt: Already over $38 trillion, this deal could further increase the debt.
continue reading...
questions
How will the new Medicare coverage for GLP-1 drugs impact the overall healthcare budget in the long term?
Will there be a black market for Ozempic if people try to resell their discounted doses?
What are the potential unintended consequences of expanding Medicare coverage to include anti-obesity drugs?
actions
flag content